In this interim analysis, the LymPro assay provides multiple univariate indicators and multivariate combinations, which discriminate AD from controls. The assay appears to be a robust and reproducible measure of a key pathology of AD and the findings corroborate previously published LymPro findings. Final data from the current study will be completed by the time this abstract is presented
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links